The DOI matches its Crossref record; the references it cites are not checked yet.
Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses
Open accessPublished version of a preprint
Abstract
The tumor microenvironment can inhibit the efficacy of cancer therapies through mechanisms such as poor trafficking and exhaustion of immune cells. Here, to address this challenge, we exploited the safety, tumor tropism and ease of genetic manipulation of non-pathogenic Escherichia coli (E. coli) to deliver key immune-activating cytokines to tumors via surface display on the outer membrane of E. coli K-12 DH5α. Non-pathogenic E. coli expressing murine decoy-resistant IL18 mutein (DR18) induced robust CD8+ T and natural killer (NK) cell-dependent immune responses and suppressed tumor progression in immune-competent colorectal carcinoma and melanoma mouse models. E. coli K-12 DH5α engineered to display human DR18 potently activated mesothelin-targeting chimeric antigen receptor (CAR) NK cells and enhance their trafficking into tumors, which extended survival in an NK cell treatment-resistant mesothelioma xenograft model by enhancing TNF signaling and upregulating NK activation markers. Our live bacteria-based immunotherapeutic system safely and effectively induces potent anti-tumor responses in treatment-resistant solid tumors, motivating further evaluation of this approach in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

















![Fig. 1 | Murine decoy-resistant IL18 displayed by bacterial scaffold Lpp-OmpA induces potent anti-tumor responses in an immune-competent syngeneic mouse model (MC38). a, Schematic figure showing the surface display of cytokines in E. coli by their transformation with the cytokine-scaffold coding plasmids and the surface expression assessed by flow cytometry. b, Heatmap showing the expression levels of 8 cytokines (murine interleukin-15, mIL15; decoy resistant murine interleukin-18, mIL18-CS2; murine interleukin-21, mIL21; human IL15, hIL15; human IL18, hIL18; two types of human decoy resistant IL18, human hIL18–6-12 and, hIL18–6-29; human IL21, hIL21) displayed by 5 different bacterial scaffolds: C-IgAP, Neae, Lpp-OmpA (OmpA), YiaT181 and, YiaT232. The display levels represent median fluorescence intensity (MFI) measured by flow cytometry. c, Mean tumor volumes as assessed on day 15 post-tumor inoculation in different groups of mice treated with PBS, mIL18-CS2 (mDR18, 0.4mg/kg), mIL15 (0.4mg/kg), bacteria displaying mDR18, mIL15 or scaffold only by C-IgAP, Lpp-OmpA, YiaT181, YiaT232 or Neae (109 CFU) intratumorally (i.t.) three times on days 7, 10 and 14 (n = 6 each group)]. d, C57BL/6 mice were subcutaneously (s.c.) engrafted with 0.5 × 106 MC38 cells on one side of the flank. Starting on day 7 after tumor cell injection (tumor size 50–100 mm3), mice were treated with PBS, mDR18 (mIL18-CS2, 4mg/kg), OmpA (0.25 × 109 CFU), OmpA-mDR18 (0.25 × 109 CFU). e, f, Mean tumor growth (e) and, Kaplan–Meier survival curves (f) for mice (n = 8–10 each group) bearing MC38 tumors after treatment with OmpA-mDR18 (0.25 × 109 CFU), OmpA (0.25 × 109 CFU), mDR18 (4mg/kg) and PBS. Two-way ANOVA test for tumor growth curve (e) and Mantel-Cox test for survival curve (f). Data represent means ± SEM (c, e).](https://figures.cochat.ai/paper-figures/e679e0601ce2439f842e792a2cc8bc82/non-pathogenic-e-coli-displaying-decoy-resistant-il18-mutein-boosts-anti-tumor-figure-18.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lastly, Yang et al. (2024) modified E. coli to enforce murine decoy-resistant IL-18 mutein expression, which induced CD8+ T cell– and natural killer cell–dependent immune responses and long-term antitumor responses against bulky cancers.”
From Microbiota-centered interventions to boost immune checkpoint blockade therapies (2025) · cites this paper as Yang et al., 2024
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 63 · Cited by 66
Research works printed but not linked: 2
- Browning, D. F., Hobman, J. L. & Busby, S. J. W. Laboratory strains of Escherichia coli K-12: things are seldom what they seem. Micro. Genom. 9, mgen000922 (2023).
- Yang, S. et al. Nonpathogenic E. coli Displaying Decoy-Resistant IL18 Mutein Enhance the Efficacy of Cancer Immunotherapies (NCBI, 2024); https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275391
Metadata
- Authors
- Yang, S., Sheffer, M., Kaplan, I. E., Wang, Z., Tarannum, M., Dinh, K., Abdulhamid, Y., Bobilev, E., Shapiro, R., Porter, R., Soiffer, R., Ritz, J., Koreth, J., Wei, Y., Chen, P., Zhang, K., Márquez-Pellegrin, V., Bonanno, S., Joshi, N., Guan, M., Yang, M., Li, D., Bellini, C., Liu, F., Chen, J., Wu, C. J., Barbie, D., Li, J., & Romee, R.
- Affiliations
- Northeastern University (US)
- Dana-Farber Cancer Institute (US)
- University of Michigan (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- Corresponding author
- Li, Jiahe
- Romee, Rizwan
- ORCID
- Yang, Shaobo
- Sheffer, Michal
- Kaplan, Isabel E.
- Wang, Zongqi
- Tarannum, Mubin
- Dinh, Khanhlinh
- Abdulhamid, Yasmin
- Bobilev, Eden
- Shapiro, Roman
- Porter, Rebecca
- Soiffer, Robert
- Ritz, Jerome
- Koreth, John
- Wei, Yun
- Chen, Peiru
- Zhang, Ke
- Bonanno, Shanna
- Yang, Mengdi
- Li, Deng
- Bellini, Chiara
- Liu, Fuguo
- Chen, Jianzhu
- Wu, Catherine J.
- Barbie, David
- Li, Jiahe
- Romee, Rizwan
- Venue
- Nature Biotechnology
- Published
- 2024-10-04
- Volume
- 43
- Issue
- 8
- Pages
- 1311-1323
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC10984091
- OpenAlex
- W4403136515
- Cited by
- 66
- References
- 63
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 4
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Biotechnology (publishedVersion)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- Funders
- Leukemia and Lymphoma Society
- Gilead Sciences
- Dana-Farber Cancer Institute
- Parker Institute for Cancer Immunotherapy
- National Institutes of Health
- National Cancer Institute (P01CA229092)
- National Institute of General Medical Sciences (DP2GM154019)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- non-pathogenic Escherichia coli, bacterial surface display, IL-18, cancer immunotherapy, CAR-NK cells, mesothelin, mesothelioma, colorectal cancer, melanoma, tumor microenvironment, NK cell trafficking, TNF signaling, CD8+ T cells, tumor tropism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses. https://app.cochat.ai/papers/10.1038/s41587-024-02418-6
- The paper
- Yang, S., Sheffer, M., Kaplan, I. E., Wang, Z., Tarannum, M., Dinh, K., Abdulhamid, Y., Bobilev, E., Shapiro, R., Porter, R., Soiffer, R., Ritz, J., Koreth, J., Wei, Y., Chen, P., Zhang, K., Márquez-Pellegrin, V., Bonanno, S., Joshi, N., . . . Romee, R. (2025). Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses. Nature Biotechnology. https://doi.org/10.1038/s41587-024-02418-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.